SCHEMBL38650880

SCHEMBL38650880

O=C(NO)c1cc2c(o1)C(=O)c1ccccc1C2=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 10/20 0.69
ALDH1A1 P00352 3/20 0.69
BCL2 P10415 1/20 0.39
MCL1 Q07820 1/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
CDC25B P30305 1/20 0.39
ACE2 Q9BYF1 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
MAPT P10636 3/20 0.38
HTT P42858 2/20 0.38
RAB9A P51151 2/20 0.38
APAF1 O14727 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MITF O75030 1/20 0.38
LMNA P02545 1/20 0.38
TTR P02766 1/20 0.38
NPC1 O15118 1/20 0.37
MAOA P21397 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38651000 0.85 STAT3 (0.55) STAT3ALDH1A1ACE2HDAC4HDAC1
SCHEMBL38651123 0.82 STAT3 (0.61) STAT3ALDH1A1HDAC4HDAC1
SCHEMBL12640087 0.81 STAT3 (0.75) STAT3ALDH1A1BCL2MCL1KMT2A
Napabucasin SCHEMBL29349770 0.81 STAT3 (1.00) STAT3ALDH1A1BCL2MCL1KMT2A
Napabucasin SCHEMBL1883845 0.81 STAT3 (1.00) STAT3ALDH1A1BCL2MCL1KMT2A
SCHEMBL18691843 0.80 STAT3 (0.73) STAT3ALDH1A1BCL2MCL1KMT2A
SCHEMBL12640086 0.80 STAT3 (0.73) STAT3ALDH1A1BCL2MCL1KMT2A
SCHEMBL38651118 0.79 HDAC1 (0.60) STAT3ALDH1A1HDAC4HDAC1
SCHEMBL38650973 0.79 HDAC1 (0.61) STAT3ALDH1A1HDAC4HDAC1
SCHEMBL38651008 0.79 HDAC1 (0.61) STAT3ALDH1A1HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122010883-A Napabucasin derivative with double-target anti-tumor activity and preparation method and application thereof 中国海洋大学 2026-05-12 CN claimed
CN-122010883-A Napabucasin derivative with double-target anti-tumor activity and preparation method and application thereof 中国海洋大学 2026-05-12 CN disclosed